Brief: Neuphoria Therapeutics Inc - Merck Pays $15M Milestone, Extends Cash Runway To Q3 2026
15/04/2025 14:24
April 15 (Reuters) - Neuphoria Therapeutics Inc NEUP.O: NEUPHORIA THERAPEUTICS INC - MERCK PAYS $15M MILESTONE, EXTENDS CASH RUNWAY TO Q3 2026 Source text: ID:nGNX4KWhZ9 Further company coverage: NEUP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuphoria Therapeutics
See all newsBrief: Scancell And Neuphoria Therapeutics Announce Merger Agreement And Financing
NASDAQ RESUMED AT 03:25 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:20 PM
Brief: Neuphoria Therapeutics Confirms Discussions On Potential Acquisition By Scancell
Brief: Neuphoria Responds To Lynx1’S Revised Indication Of Interest At A Reduced Price And Premium